title: Quantitative analysis of piroxicam using temperature-controlled ionic liquid dispersive liquid phase microextraction followed by stopped-flow injection spectrofluorimetry.
abstract: BACKGROUND
  Piroxicam (PXM) belongs to the wide class of non-steroidal anti-inflammatory drugs (NSAIDs). PXM has been widely applied in the treatment of rheumatoid arthritis, gonarthrosis, osteoarthritis, backaches, neuralgia, mialgia. In the presented work, a green and benign sample pretreatment method called temperature-controlled ionic liquid dispersive liquid phase microextraction (TCIL-DLPME) was followed with stopped-flow injection spectrofluorimetry (SFIS) for quantitation of PXM in pharmaceutical formulations and biological samples.
  
  
  METHODS
  Temperature-controlled ionic liquid dispersive liquid phase microextraction (TCIL-DLPME) was applied as an environmentally friendly sample enrichment method to extract and isolate PXM prior to quantitation. Dispersion of 1-hexyl-3-methylimidazolium hexafluorophosphate ([Hmim][PF6]) ionic liquid (IL) through the sample aqueous solution was performed by applying a relatively high temperature. PXM was extracted into the extractor, and after phase separation, PXM in the final solution was determined by stopped-flow injection spectrofluorimetry (SFIS).
  
  
  CONCLUSIONS
  Different factors affecting the designed method such as IL amount, diluting agent, pH and temperature were investigated in details and optimized. The method provided a linear dynamic range of 0.2-150 μg l-1, a limit of detection (LOD) of 0.046 μg l-1 and a relative standard deviation (RSD) of 3.1%. Furthermore, in order to demonstrate the analytical applicability of the recommended method, it was applied for quantitation of PXM in real samples.
authors.affiliation: Department of Applied Chemistry, Faculty of science, Islamic Azad University, South Tehran Branch, Tehran, Iran. Zeeb.mohsen@gmail.com.
authors.forename: Mohsen
authors.initials: M
authors.lastname: Zeeb
authors.forename: Parisa
authors.initials: P
authors.lastname: Tayebi Jamil
authors.forename: Ali
authors.initials: A
authors.lastname: Berenjian
authors.forename: Mohammad Reza
authors.initials: MR
authors.lastname: Ganjali
authors.forename: Mohamad Reza
authors.initials: MR
authors.lastname: Talei Bavil Olyai
references.citation: J Chromatogr A. 2008 Jan 4;1177(1):43-9
references.pmid: 18045608
references.citation: J Chromatogr A. 2011 Mar 25;1218(12):1556-66
references.pmid: 21324466
references.citation: Anal Bioanal Chem. 2009 Nov;395(5):1491-502
references.pmid: 19756541
references.citation: Anal Chim Acta. 2008 Apr 14;613(1):56-63
references.pmid: 18374702
references.citation: Food Chem Toxicol. 2011 May;49(5):1086-91
references.pmid: 21272609
references.citation: Anal Chim Acta. 2006 Jan 18;556(1):38-45
references.pmid: 17723329
references.citation: J Chromatogr B Analyt Technol Biomed Life Sci. 2005 Nov 5;826(1-2):214-9
references.pmid: 16169293
references.citation: J Pharm Biomed Anal. 2002 Jul 20;29(4):729-36
references.pmid: 12093502
references.citation: Anal Chim Acta. 2009 Apr 27;640(1-2):40-6
references.pmid: 19362617
references.citation: Anal Bioanal Chem. 2005 Feb;381(4):907-12
references.pmid: 15655669
references.citation: J Pharm Biomed Anal. 2000 Jan;21(6):1171-82
references.pmid: 10708401
references.citation: Daru. 2011;19(6):446-54
references.pmid: 23008691
references.citation: Spectrochim Acta A Mol Biomol Spectrosc. 2003 Apr;59(6):1213-22
references.pmid: 12659890